Secondary tabs
Contact details
David Pittrow
Main
Marius Hoeper
Alternate
Publications
Data source publications
- Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry
- Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
- Incidence and prevalence of pulmonary arterial hypertension in Germany
- Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum
- Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
- Risk assessment in pulmonary arterial hypertension
- The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry
- Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
- Risk stratification in pulmonary arterial hypertension using Bayesian analysis
- Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry
- COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
- Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
- Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
- Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
- Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
- Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry
- Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables
- Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis
- Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis